Literature DB >> 10845561

Downregulation of the urokinase-type plasminogen activator receptor through inhibition of translation by antisense oligonucleotide suppresses invasion of human glioblastoma cells.

P M Mohan1, S S Lakka, S Mohanam, Y Kin, R Sawaya, A P Kyritsis, G L Nicolson, J S Rao.   

Abstract

We previously showed that downregulation of the urokinase-type plasminogen activator receptor (uPAR) in the SNB19 human glioblastoma cell line by the stable transfection of a plasmid expressing a 300 bp antisense sequence to the 5' end of the uPAR gene produced a decrease in the amount of target mRNA. In a more recent study, we found that adenovirus-mediated transduction (Ad-uPAR) of the same uPAR antisense gene construct in SNB19 cells also downregulated uPAR protein levels. We report here that Ad-uPAR-transfected SNB19 cells produced the same amounts of target uPAR mRNA but significantly less protein by in vitro translation and by in situ [35S] labeling compared to Ad-CMV vector-transfected and mock-transfected cells. This antisense construct also inhibited glioblastoma cell invasion confirming previous results. We conclude that downregulation of uPAR by this antisense gene construct results from inhibition of protein translation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10845561     DOI: 10.1023/a:1006779902978

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  25 in total

Review 1.  The role of plasminogen activators in the regulation of connective tissue metalloproteinases.

Authors:  G Murphy; S Atkinson; R Ward; J Gavrilovic; J J Reynolds
Journal:  Ann N Y Acad Sci       Date:  1992-12-04       Impact factor: 5.691

Review 2.  The urokinase receptor: involvement in cell surface proteolysis and cancer invasion.

Authors:  V Ellis; C Pyke; J Eriksen; H Solberg; K Danø
Journal:  Ann N Y Acad Sci       Date:  1992-12-04       Impact factor: 5.691

Review 3.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids.

Authors:  C Hélène; J J Toulmé
Journal:  Biochim Biophys Acta       Date:  1990-06-21

4.  In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.

Authors:  S Mohanam; S K Chintala; Y Go; A Bhattacharya; B Venkaiah; D Boyd; Z L Gokaslan; R Sawaya; J S Rao
Journal:  Oncogene       Date:  1997-03-20       Impact factor: 9.867

5.  V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

Authors:  R Landgraf; R Gerstberger; A Montkowski; J C Probst; C T Wotjak; F Holsboer; M Engelmann
Journal:  J Neurosci       Date:  1995-06       Impact factor: 6.167

Review 6.  Molecular aspects of tumor cell invasion and metastasis.

Authors:  S Aznavoorian; A N Murphy; W G Stetler-Stevenson; L A Liotta
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

7.  Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice.

Authors:  H Li; H Lu; F Griscelli; P Opolon; L Q Sun; T Ragot; Y Legrand; D Belin; J Soria; C Soria; M Perricaudet; P Yeh
Journal:  Gene Ther       Date:  1998-08       Impact factor: 5.250

8.  Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro.

Authors:  A Stahl; B M Mueller
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

9.  Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.

Authors:  C Wahlestedt; E Golanov; S Yamamoto; F Yee; H Ericson; H Yoo; C E Inturrisi; D J Reis
Journal:  Nature       Date:  1993-05-20       Impact factor: 49.962

10.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.

Authors:  J D Vassalli; D Baccino; D Belin
Journal:  J Cell Biol       Date:  1985-01       Impact factor: 10.539

View more
  10 in total

1.  RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells.

Authors:  Christopher S Gondi; Neelima Kandhukuri; Shakuntala Kondraganti; Meena Gujrati; William C Olivero; Dzung H Dinh; Jasti S Rao
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

Review 2.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells.

Authors:  Satoshi Takahashi; Hisafumi Yamada-Okabe; Kenji Hamada; Shigeki Ohta; Takeshi Kawase; Kazunari Yoshida; Masahiro Toda
Journal:  J Neurooncol       Date:  2010-09-16       Impact factor: 4.130

4.  uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells.

Authors:  Hari Raghu; Arun Kumar Nalla; Christopher S Gondi; Meena Gujrati; Dzunh H Dinh; Jasti S Rao
Journal:  Mol Oncol       Date:  2011-11-30       Impact factor: 6.603

5.  Co-depletion of cathepsin B and uPAR induces G0/G1 arrest in glioma via FOXO3a mediated p27 upregulation.

Authors:  Sreelatha Gopinath; Rama Rao Malla; Christopher S Gondi; Kiranmai Alapati; Daniel Fassett; Jeffrey D Klopfenstein; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

6.  siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.

Authors:  Ramesh Subramanian; Christopher S Gondi; Sajani S Lakka; Aman Jutla; Jasti S Rao
Journal:  Int J Oncol       Date:  2006-04       Impact factor: 5.650

7.  Suppression of uPA and uPAR attenuates angiogenin mediated angiogenesis in endothelial and glioblastoma cell lines.

Authors:  Hari Raghu; Sajani S Lakka; Christopher S Gondi; Sanjeeva Mohanam; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

8.  Inhibition of NF- κ B by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and γ -Radiation Cytotoxicity in Glioblastoma Cells.

Authors:  M S Brassesco; G M Roberto; A G Morales; J C Oliveira; L E A Delsin; J A Pezuk; E T Valera; C G Carlotti; E M Rego; H F de Oliveira; C A Scrideli; K Umezawa; L G Tone
Journal:  Chemother Res Pract       Date:  2013-02-21

9.  Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.

Authors:  N Ahmed; K Oliva; Y Wang; M Quinn; G Rice
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

10.  Tyrosine-kinase inhibition results in EGFR clustering at focal adhesions and consequent exocytosis in uPAR down-regulated cells of head and neck cancers.

Authors:  Samah Abu-Ali; Abbas Fotovati; Kanemitsu Shirasuna
Journal:  Mol Cancer       Date:  2008-06-03       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.